Abivax SA American Depositary Shares (ABVX) Stock Price

ABVXStock

$113.35+36.22%52W

Market Cap$9.89B

P/E—

PEG Ratio—

Div yield—

Beta0.65

ABVX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.04%

Price vs S&P 500 (4W)-10.77%

VGM Score51.04

Book Value / Share (Quarterly)$6.72

P/TBV (Annual)20.15x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-2.31

Price vs S&P 500 (YTD)-30.55%

EPS (TTM)$-6.16

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-6.16

EPS (Annual)$-5.61

ROI (Annual)-73.54%

Gross Margin (Annual)-19700.00%

Cash / Share (Quarterly)$7.95

ROA (Last FY)-57.52%

EBITD / Share (TTM)$-4.81

ROE (5Y Avg)-314.42%

Cash Flow / Share (Annual)$-2.31

P/B Ratio20.95x

P/B Ratio (Quarterly)19.86x

Net Income / Employee (Annual)$-5,732,029

Net Interest Coverage (TTM)-5.62x

ROA (TTM)-133.81%

EPS Incl Extra (Annual)$-5.61

Current Ratio (Annual)8.75x

Quick Ratio (Quarterly)8.71x

3-Month Avg Trading Volume0.26M

52-Week Price Return36.22%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$6.62

P/S Ratio (Annual)953684.10x

Asset Turnover (Annual)0.00x

52-Week High$161.20

EPS Excl Extra (Annual)$-5.61

CapEx CAGR (5Y)-30.85%

Tangible BV CAGR (5Y)142.88%

26-Week Price Return-8.11%

Quick Ratio (Annual)8.71x

13-Week Price Return-12.88%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.75x

Enterprise Value$10.46B

Book Value / Share Growth (5Y)77.81%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-58600.00%

Cash / Share (Annual)$7.95

3-Month Return Std Dev130.46%

Net Income / Employee (TTM)$-6,558,544

ROE (Last FY)-73.84%

Net Interest Coverage (Annual)-5.89x

EPS Basic Excl Extra (Annual)$-5.61

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-6.16

Receivables Turnover (Annual)0.00x

ROI (TTM)-51.49%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$6.62

Price vs S&P 500 (52W)17.67%

Year-to-Date Return-19.10%

5-Day Price Return-0.71%

EPS Normalized (Annual)$-5.61

ROA (5Y Avg)-61.29%

Net Profit Margin (Annual)-50800.00%

Month-to-Date Return-8.37%

Cash Flow / Share (TTM)$-3.47

EBITD / Share (Annual)$-4.09

Operating Margin (Annual)-57900.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-86.76%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-6.16

P/TBV (Quarterly)20.15x

P/B Ratio (Annual)19.86x

Book Value / Share (Annual)$6.72

Price vs S&P 500 (13W)-14.83%

Beta0.65x

Revenue / Share (TTM)$0.00

ROE (TTM)-51.69%

52-Week Low$70.10

mGradeC

vgmGradeC

ABVX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	May 22, 2026	-$0.94	-$0.82	+12.81%(+$0.12)
Q4 2025	Mar 23, 2026	-$1.21	-$1.37	-13.05%(-$0.16)
Q3 2025	Dec 15, 2025	-$0.91	-$2.86	-214.01%(-$1.95)
Q2 2025	Sep 8, 2025	-$1.10	-$1.04	+6.10%(+$0.07)

ABVX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.29

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	C	C	B	$17.54

About Abivax SA American Depositary Shares

Abivax is a French clinical-stage biotechnology company developing therapeutics designed to regulate immune response in chronic inflammatory diseases. The company's lead candidate, obefazimod, is in Phase 3 development for moderately to severely active ulcerative colitis. Abivax focuses on inflammatory bowel disease, including both ulcerative colitis and Crohn's disease.